Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Amdizalisib by Hutchison MediPharma for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma): Likelihood of Approval
Amdizalisib is under clinical development by Hutchison MediPharma and currently in Phase I for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated...
Data Insights
Amdizalisib by Hutchison MediPharma for Nodal Marginal Zone B-Cell Lymphoma: Likelihood of Approval
Amdizalisib is under clinical development by Hutchison MediPharma and currently in Phase I for Nodal Marginal Zone B-Cell Lymphoma. According...